Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$1M
1 round on record
Latest round
$1M
Convertible Note · Sep 2026 · 1 mo ago
Backers
1
Illinois Ventures
The money's age
Fresh money
1 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 2026 Formerly Coologics (coologics.com) Sep 1 Raised a round Convertible Note $1M · SEC Form D 2025 Founded
Funding rounds
RoundDateAmountInvestorsSource
Convertible Note Sep 2026 $1M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Coologics, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Kimberly LangdonExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs

Overview

Coologics is a clinical-stage medical device company developing a drug-free solution for vaginal yeast and bacterial infections using patented controlled-cooling technology.

People

Kimberly Langdon
Executive Officer, Director
Gregory Hickman
Director
Dale Hunt
Director
Timothy Bledsoe
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Grove City United States
HQ

Financials

Total raised
$1M
Latest round
Convertible Note
Funding rounds
1
Funding rounds
Round Announced Amount
Convertible Note 2026 $1M Details